BRAIDWELL LP

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1920938 STAMFORD, CT

Position in MRVI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$28,979,664

+$1,831,482 QoQ

Shares Held

10,240,164

+22.6% QoQ

Ownership

3.97%

of shares outstanding

% of Portfolio

1.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BRAIDWELL LP holds $1,648,117,197 across 48 Biotechnology names. MRVI ranks #21 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CAI	Caris Life Sciences, Inc.	8,009,447	$143,208,912
2	CNTA	Centessa Pharmaceuticals plc	1,986,768	$78,914,424
3	XENE	Xenon Pharmaceuticals Inc.	1,338,452	$77,830,983
4	DNTH	Dianthus Therapeutics, Inc. /DE/	899,364	$75,474,626
5	EWTX	Edgewise Therapeutics, Inc.	2,347,583	$73,948,864
6	NUVL	Nuvalent, Inc.	700,429	$71,758,951
7	KOD	Kodiak Sciences Inc.	1,818,665	$69,327,509
8	CGON	CG Oncology, Inc.	984,783	$66,650,113

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$28,979,664	10,240,164	+22.6%	Shares	Sole	2026-05-15
2025-12-31	$27,148,182	8,353,287	0.0%	Shares	Sole	2026-02-17
2025-09-30	$23,973,933	8,353,287	0.0%	Shares	Sole	2025-11-14
2025-06-30	$20,131,421	8,353,287	0.0%	Shares	Sole	2025-08-14
2025-03-31	$18,460,764	8,353,287	0.0%	Shares	Sole	2025-05-15
2024-12-31	$45,525,414	8,353,287	0.0%	Shares	Sole	2025-02-14
2024-09-30	$69,415,814	8,353,287	-7.4%	Shares	Sole	2024-11-14
2024-06-30	$64,612,104	9,024,037	+25.0%	Shares	Sole	2024-08-14
2024-03-31	$62,614,393	7,221,960	+43.3%	Shares	Sole	2024-05-15
2023-12-31	$33,016,159	5,040,635	+26.8%	Shares	Sole	2024-02-14
2023-09-30	$39,748,570	3,974,857	+120.3%	Shares	Sole	2023-11-14
2023-06-30	$22,432,421	1,804,700	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.